Rio Branco
Rio Branco
Rio Branco, Acre, Brazil6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-09-10 | NCT06024746 | |
| A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-09-10 | NCT06008197 | |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-08-18 | NCT07567001 | |
| A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-07-10 | NCT06033950 | |
| National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry | Abnormalities, Multiple, Aneurysm, Aortic Dissection, Arrhythmias, Cardiac, Bone Diseases, Developmental, Brugada syndrome, Cardiac Conduction System Disease, Cardiomegaly, Cardiovascular Abnormalities, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Death, Death, Sudden, Death, Sudden, Cardiac, Dissection, Blood Vessel, Dyslipidemias, Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, vascular type, Hemic and Lymphatic Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Loeys-Dietz syndrome, Marfan syndrome, Musculoskeletal Abnormalities, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Polymorphic Catecholaminergic Ventricular Tachycardia, Skin Abnormalities, Skin and Connective Tissue Diseases, Tachycardia, aortic aneurysm, aortic disorder, aortic valve disorder, aortic valve stenosis, arrhythmogenic right ventricular cardiomyopathy, bone disorder, cardiac arrest, cardiomyopathy, cardiovascular disorder, congenital heart disease, connective tissue disorder, dilated cardiomyopathy, familial hypercholesterolemia, heart disorder, heart valve disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary skin disorder, hyperlipidemia, hyperlipoproteinemia, hypertrophic cardiomyopathy, inborn errors of metabolism, laminopathy, metabolic disease, musculoskeletal system disorder, non-compaction cardiomyopathy, restrictive cardiomyopathy, short QT syndrome, skin disorder, subvalvular aortic stenosis, vascular disorder, vascular hemostatic disease, ventricular tachycardia | Recruiting | Not stated | 2026-05-08 | NCT06546137 | |
| EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction | Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Phase 4 | 2025-10-06 | NCT05284747 |